This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
RNF149 Monoclonal Antibody (OTI9F11)
catalog :
MA5-27311
quantity :
100 uL
price :
US 504.00
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
OTI9F11
The same clone is also sold as:
The same clone is also sold as:
- OriGene: CF810509, TA810509BM, TA810509AM, TA810509S, TA810509
reactivity :
human
application :
western blot
product information
Product Type :
Antibody
Product Name :
RNF149 Monoclonal Antibody (OTI9F11)
Catalog # :
MA5-27311
Quantity :
100 uL
Price :
US 504.00
Clonality :
Monoclonal
Purity :
Affinity Chromatography
Host :
Mouse
Reactivity :
Human
Applications :
Western Blot: 1:500-1:2,000
Species :
Human
Clone :
OTI9F11
Isotype :
IgG1
Storage :
-20 C, Avoid Freeze/Thaw Cycles
Description :
RNF149 is a E3 ubiquitin-protein ligase. Ubiquitinates BRAF, inducing its proteasomal degradation.
Immunogen :
Human recombinant protein fragment corresponding to amino acids 250-383 of RNF149 produced in E.coli
Format :
Liquid
Applications w/Dilutions :
Western Blot: 1:500-1:2,000
Aliases :
1600023E10Rik; AV037261; C76763; DNA polymerase-transactivated protein 2; DNAPTP2; E3 ubiquitin-protein ligase RNF149; Gm15832; Goliath-related E3 ubiquitin-protein ligase 4; Greul4; OTTMUSG00000026591; RING finger protein 149; RING-type E3 ubiquitin transferase RNF149; RNF149
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments